AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 526262: 1,3,4,6,7-Pentabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,3,4,6,7-pentabromodibenzofuran. Molecular Formula: C12H3Br5O. Molecular Weight: 562.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
PLACES: Census Tract Data (GIS Friendly Format), 2024 release

This dataset contains model-based census tract level estimates in GIS-friendly format. PLACES covers the entire United States—50 states and the District of Columbia—at county, place, census tract, and ZIP Code Tabulation Area levels. It provides information uniformly on this large scale for local areas at four geographic levels. Estimates were provided by the Centers for Disease Control and Prevention (CDC), Division of Population Health, Epidemiology and Surveillance Branch. PLACES was funded by the Robert Wood Johnson Foundation in conjunction with the CDC Foundation. Data sources used to generate these model-based estimates are Behavioral Risk Factor Surveillance System (BRFSS) 2022 or 2021 data, Census Bureau 2010 population estimates, and American Community Survey (ACS) 2015–2019 estimates. The 2024 release uses 2022 BRFSS data for 36 measures and 2021 BRFSS data for 4 measures (high blood pressure, high cholesterol, cholesterol screening, and taking medicine for high blood pressure control among those with high blood pressure) that the survey collects data on every other year. These data can be joined with the Census tract 2022 boundary file in a GIS system to produce maps for 40 measures at the census tract level. An ArcGIS Online feature service is also available for users to make maps online or to add data to desktop GIS software.
https://cdcarcgis.maps.arcgis.com/home/item.html?id=3b7221d4e47740cab9235b839fa55cd7
Compound 525612: N,N-Dimethyl-N'-benzyl-p-methoxybenzamidine

Chemical compound data from PubChem database. IUPAC Name: N'-benzyl-4-methoxy-N,N-dimethylbenzenecarboximidamide. Molecular Formula: C17H20N2O. Molecular Weight: 268.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B

NNDSS - TABLE 1W. Meningococcal disease, All serogroups to Meningococcal disease, Serogroup B - 2020. In this Table, provisional cases* of notifiable diseases are displayed for United States, U.S. territories, and Non-U.S. residents.

Note: 
This table contains provisional cases of national notifiable diseases from the National Notifiable Diseases Surveillance System (NNDSS). NNDSS data from the 50 states, New York City, the District of Columbia and the U.S. territories are collated and published weekly on the NNDSS Data and Statistics web page (https://wwwn.cdc.gov/nndss/data-and-statistics.html). Cases reported by state health departments to CDC for weekly publication are provisional because of the time needed to complete case follow-up. Therefore, numbers presented in later weeks may reflect changes made to these counts as additional information becomes available. The national surveillance case definitions used to define a case are available on the NNDSS web site at https://wwwn.cdc.gov/nndss/. Information about the weekly provisional data and guides to interpreting data are available at: https://wwwn.cdc.gov/nndss/infectious-tables.html. 

Footnotes:
U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
-: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
NP: Nationally notifiable but not published.
NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
Cum: Cumulative year-to-date counts.
Max: Maximum — Maximum case count during the previous 52 weeks.
* Case counts for reporting years 2019 and 2020 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://wwwn.cdc.gov/nndss/document/Users_guide_WONDER_tables_cleared_final.pdf.
†Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
Compound 529766: 2-Methyl-1,4-dithiepane

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-1,4-dithiepane. Molecular Formula: C6H12S2. Molecular Weight: 148.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Washington (WA)

This report uses 2008 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past year alcohol use disorder and illicit drug use disorder among persons aged 12 or older for Washington overall and for substate regions within Washington. Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE).
COVID-19 State Profile Report -  Combined Set

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
MD COVID-19 - MASTER Case Tracker

<b>Note:</b> Starting April 27, 2023 updates change from daily to weekly.

<b>Summary</b>
The cases, tests, positivity rates, hospitalizations, and confirmed and probable deaths for COVID-19 in Maryland.

<b>Description</b>
The MD COVID-19 - MASTER Case Tracker is a collection of Total Cases, Total Tests, Postivity Rates, Persons Tested Negative, Total Daily Hospital Beds, Total Ever Hospitalized, Total Persons Documented to Have Completed Home Isolation, Cases by County, Cases by Age Distribution, Cases by Gender Distribution, Cases by Race and Ethnicity Distribution, Confirmed Deaths Statewide, Confirmed Deaths by Date of Death, Confirmed Deaths by County, Confirmed Deaths by Age Distribution, Confirmed Deaths by Gender Distribution, Confirmed Deaths by Race And Ethnicity Distribution, Probable Deaths Statewide, Probable Deaths by Date of Death, Probable Deaths by County, Probable Deaths by Age Distribution, Probable Deaths by Gender Distribution, and Probable Deaths by Race And Ethnicity Distribution.

<b>Terms of Use</b>
The Spatial Data, and the information therein, (collectively the "Data") is provided "as is" without warranty of any kind, either expressed, implied, or statutory. The user assumes the entire risk as to quality and performance of the Data. No guarantee of accuracy is granted, nor is any responsibility for reliance thereon assumed. In no event shall the State of Maryland be liable for direct, indirect, incidental, consequential or special damages of any kind. The State of Maryland does not accept liability for any damages or misrepresentation caused by inaccuracies in the Data or as a result to changes to the Data, nor is there responsibility assumed to maintain the Data in any manner or form. The Data can be freely distributed as long as the metadata entry is not modified or deleted. Any data derived from the Data must acknowledge the State of Maryland in the metadata.
Compound 527093: Citalopram, bis-nor, acetyl

Chemical compound data from PubChem database. IUPAC Name: N-[3-[5-cyano-1-(4-fluorophenyl)-3H-2-benzofuran-1-yl]propyl]acetamide. Molecular Formula: C20H19FN2O2. Molecular Weight: 338.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Delaware (DE)

This report uses 2008 to 2010 National Survey on Drug Use and Health (NSDUH) to assess past year alcohol use disorder and illicit drug use disorder among persons aged 12 or older for Delaware overall and for substate regions within Delaware. Topics covered include past month substance use (e.g., illicit drugs, marijuana, cocaine, pain relievers, alcohol, tobacco), substance dependence, abuse, and treatment need, past year serious mental illness (SMI), any mental illness (AMI), suicidal thoughts, and major depressive episode (MDE).
Compound 527493: Methyl 2'-hydroxy-6'-isopropoxy-4,6-dimethoxy-4'-methyl[1,1'-biphenyl]-2-carboxylate

Chemical compound data from PubChem database. IUPAC Name: 8-chloro-4-methoxy-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine. Molecular Formula: C19H20ClN3O2. Molecular Weight: 357.8. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401774-T1: [Translated] IMPROVEMENTS TO A VEGETATION CUTTING APPARATUS

The present invention relates to improvements in or relating to vegetation cutter apparatus. In particular, it relates to improvements in construction and manufacture of housings for lawn mowers. We describe a lawnmower having a deck with a lower surface defining a cutting chamber, a cutting element mounted within the cutting chamber, a motor assembly driving the cutter element, the motor being mounted on an upper surface of the deck, wherein the vegetation cutting apparatus further comprises a discharge chute having a discharge chute inlet in communication with the cutting chamber and a discharge chute outlet, a cover covering at least a portion of the motor assembly, and a pivotable deflector guard biased into a closed configuration against the discharge chute outlet. The discharge chute comprises a chute floor, chute sides and a chute roof. The present invention is characterised in that at least a portion of the chute roof is formed by a portion of the motor cover.
Compound 530390: Benzaldehyde, 2-hydroxy-3-methoxy, O-methyloxime

Chemical compound data from PubChem database. IUPAC Name: 2-methoxy-6-(methoxyiminomethyl)phenol. Molecular Formula: C9H11NO3. Molecular Weight: 181.19. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528260: Butanedioic acid, decyl phenylmethyl ester

Chemical compound data from PubChem database. IUPAC Name: 4-O-benzyl 1-O-decyl butanedioate. Molecular Formula: C21H32O4. Molecular Weight: 348.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
N-SUMHSS 2024 Questionnaire

This is the questionnaire for the 2024 National Substance Use and Mental Health Services Survey (N-SUMHSS). The N-SUMHSS is a voluntary annual survey of all active substance use and mental health facilities in the United States, its jurisdictions, and the District of Columbia. This document shows the series of questions substance use and mental health treatment facilities were asked for the N-SUMHSS.The survey consists of two introductory questions and four separate modules. Skip patterns in the survey direct participants on relevant modules depending on whether the facility is a substance use treatment facility, a mental health treatment facility, or both.Facilities operated by the Department of Veteran’s Affairs (VA) were asked to complete additional questions regarding VA services offered. Additionally, all substance use and mental health facilities were asked to complete additional questions regarding electronic health records.The questionnaire for N-SUMHSS and its supplement(s) is available as a PDF file.
Seattle: Drug-Related Emergency Department Visits, 2004-2011 - Accidental Ingestions

Excel file with estimates, rates, relative standard errors, trends and confidence intervals, covering 2004-2011 for emergency department visits involving accidental ingestions in the Seattle metropolitan area. This analytic category includes ED visits in which an individual accidentally or unknowingly used or was administered a prescription drug, over-the-counter medication, or dietary supplement. Drug-related accidental ingestion typically involves patients aged 5 and under.  This analytic category does not include drug misuse or abuse.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Compound 529252: Oxetane, 3-bromomethyl-3-(4-methylphenyloxy)methyl

Chemical compound data from PubChem database. IUPAC Name: 3-(bromomethyl)-3-[(4-methylphenoxy)methyl]oxetane. Molecular Formula: C12H15BrO2. Molecular Weight: 271.15. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525618: N,N-Dimethyl-N'-cyclohexyl-benzamidine

Chemical compound data from PubChem database. IUPAC Name: N'-cyclohexyl-N,N-dimethylbenzenecarboximidamide. Molecular Formula: C15H22N2. Molecular Weight: 230.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530558: 4-Ethylbenzoic acid, octadecyl ester

Chemical compound data from PubChem database. IUPAC Name: octadecyl 4-ethylbenzoate. Molecular Formula: C27H46O2. Molecular Weight: 402.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Introducing a reward system in assessment in histology: A comment on the learning strategies it might engender

Background
          Assessment, as an inextricable component of the curriculum, is an important factor influencing student approaches to learning. If assessment is to drive learning, then it must assess the desired outcomes. In an effort to alleviate some of the anxiety associated with a traditional discipline-based second year of medical studies, a bonus system was introduced into the Histology assessment. Students obtaining a year mark of 70% were rewarded with full marks for some tests, resulting in many requiring only a few percentage points in the final examination to pass Histology.
        
        
          Methods
          In order to ascertain whether this bonus system might be impacting positively on student learning, thirty-two second year medical students (non-randomly selected, representing four academic groups based on their mid-year results) were interviewed in 1997 and, in 1999, the entire second year class completed a questionnaire (n = 189). Both groups were asked their opinions of the bonus system.
        
        
          Results
          Both groups overwhelming voted in favour of the bonus system, despite less than 45% of students failing to achieve it. Students commented that it relieved some of the stress of the year-end examinations, and was generally motivating with regard to their work commitment.
        
        
          Conclusions
          Being satisfied with how and what we assess in Histology, we are of the opinion that this reward system may contribute to engendering appropriate learning approaches (i.e. for understanding) in students. As a result of its apparent positive influence on learning and attitudes towards learning, this bonus system will continue to operate until the traditional programme is phased out. It is hoped that other educators, believing that their assessment is a reflection of the intended outcomes, might recognise merit in rewarding students for consistent achievement.
HCUP Nationwide Readmissions Database (NRD)- Restricted Access Files

The Healthcare Cost and Utilization Project (HCUP) Nationwide Readmissions Database (NRD) is a unique and powerful database designed to support various types of analyses of national readmission rates for all payers and the uninsured. The NRD includes discharges for patients with and without repeat hospital visits in a year and those who have died in the hospital. Repeat stays may or may not be related. The criteria to determine the relationship between hospital admissions is left to the analyst using the NRD. This database addresses a large gap in health care data - the lack of nationally representative information on hospital readmissions for all ages.  Outcomes of interest include national readmission rates, reasons for returning to the hospital for care, and the hospital costs for discharges with and without readmissions. Unweighted, the NRD contains data from approximately 18 million discharges each year. Weighted, it estimates roughly 35 million discharges. Developed through a Federal-State-Industry partnership sponsored by the Agency for Healthcare Research and Quality, HCUP data inform decision making at the national, State, and community levels. 

The NRD is drawn from HCUP State Inpatient Databases (SID) containing verified patient linkage numbers that can be used to track a person across hospitals within a State, while adhering to strict privacy guidelines.  The NRD is not designed to support regional, State-, or hospital-specific readmission analyses.  

The NRD contains more than 100 clinical and non-clinical data elements provided in a hospital discharge abstract. Data elements include but are not limited to: diagnoses, procedures, patient demographics (e.g., sex, age), expected source of payer, regardless of expected payer, including but not limited to Medicare, Medicaid, private insurance, self-pay, or those billed as ‘no charge, discharge month, quarter, and year, total charges, length of stay, and data elements essential to readmission analyses.  The NIS excludes data elements that could directly or indirectly identify individuals. 

Restricted access data files are available with a data use agreement and brief online security training.
Patent AT-E40124-T1: [Translated] HERBICIDES AND INSECTICIDES TRIAZINONES.

The invention relates to 4-methylamino-1,2,4-triazin-5-one of the formula I    <IMAGE>  (I)  wherein R1 is C3-C8 cycloalkyl or C3-C8 cycloalkyl which is substituted by C1-C4alkyl; C3-C8halocycloalkyl, C3-C8alkyl, C3-C8haloalkyl, 2-furyl, 2-thienyl, phenyl, benzyl, or phenyl or benzyl each substituted by one or more members selected from the group consisting of halogen, C1-C4alkyl, C1-C4haloalkyl, C1-C4alkoxy or C1-C4haloalkoxy, R2 is hydrogen or methyl, and R3 is cyclopropyl, cyclopropylmethyl, C1-C4alkyl, C3-C4alkenyl or C3-C4alkynyl. These compounds have selective herbicidal properties and are therefore pre-eminently suitable for controlling weeds in crops of useful plants, for example in cereals, maize, soybeans and sugar cane. They are also suitable for controlling harmful insects.
Patent AT-E401148-T1: [Translated] METHOD AND DEVICE FOR SEPARATING ROD-SHAPED BODY

The method involves moving a gripper (19) along a body (6) and upto a lateral end region of the body for lifting the body out of a bundle (5). The body is moved to a vertical position with the gripper, where the vertical position is higher than predetermined minimum height. Vertical center lines of a sensor (17), the gripper and another gripper (18) are located in a common vertical plane extending transversely perpendicular to a conveying direction. The picked-up body is moved to a depositing location by using the grippers, or the picked-up body is held in a holding position for transfer. An independent claim is also included for an apparatus for separating rod-shaped bodies from a bundle of bodies.
CCWIS Status at the End of Transition Period (July 31, 2018)

The following tables show the status of child welfare information systems or projects in the states and tribes as of July 31, 2018.

As of July 31, 2018, 46 states, the District of Columbia, and Puerto Rico declared as CCWIS.

The following is the key for the table columns. Values represented are as of July 31, 2018:

Note: The definitions of a S/TACWIS project and a non-S/TACWIS project can be found in the CCWIS regulation at 45 CFR § 1355.51
  
  

 (PDF). CCWIS project and non-CCWIS project requirements can be found in the CCWIS regulation at 45 CFR § 1355.52—1355.55
  
  

 (PDF).

Metadata-only record linking to the original dataset. Open original dataset below.
Behavioral Health Barometer: South Carolina, 2014

This is a behavioral health report for the state of South Carolina. It uses the  National Survey on Drug Use and Health (NSDUH) and the National Survey of Substance Abuse Treatment Services (NSSATS) to address the topics of youth substance use , youth mental health and treatment, adult mental health and treatment, substance use, substance use treatment, and medicare enrollees for the years 2009 to 2013.
Patent AT-E399774-T1: [Translated] N-(IMINOMETHYL)AMINE DERIVATIVES, THEIR PRODUCTION, THEIR USE IN MEDICATIONS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM

Chemical patent from PubChem database. Patent Number: AT-E399774-T1. Title: Bioactive Compound and Applications. Filing Date: 1993-06-22. Inventors: Anderson, Robert, Davis, Linda. Abstract: A bioactive compound and its applications in pharmaceutical and agricultural fields are described. The compound exhibits significant biological activi... IPC Classifications: A61K, A61L, A61F. This patent covers 24 claims related to 9 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.